microdosing glp 1 for perimenopause GLP-1 Agonists in Perimenopause: Unique Risks and Potential Opportunities Thinking About Microdosing GLP-1? 5

When staying with tirzepatide makes more sense Tirzepatide remains the better choice in several scenarios

Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials

The KTTKS sequence is derived from the C-terminal propeptide of type I procollagen and acts as a matrikine -- a peptide fragment that signals cells to produce new extracellular matrix components

Patients commonly experience gastrointestinal side effects during the initial weeks and following dose increases, including nausea, diarrhea, decreased appetite, and occasional vomiting

I find that being transparent about treatment expectations helps patients understand their journey, explains Dr

If rash and/or irritation occurs, stop using and see your doctor